PMI Vice President: Adoption of Smoke-Free Technologies in Africa Is Slow, Company to Step Up Promotion Efforts

Jul.09.2025
PMI Vice President: Adoption of Smoke-Free Technologies in Africa Is Slow, Company to Step Up Promotion Efforts
Africa faces both challenges and opportunities in tobacco control, with the rollout of new technologies progressing slowly and public health requiring urgent attention. Philip Morris International (PMI) says it will continue promoting innovative technologies to accelerate the transformation of tobacco products.

Key Points:

 

·The slow adoption of new tobacco technology in Africa has raised public health concerns, with the tobacco industry interference, weak regulatory framework, and lack of public awareness slowing down technology dissemination. 

 

·Philip Morris International (PMI) has warned that delays in technology adoption could hinder disease control progress. 

 


【2Firsts News Flash】According to Nyasa Times reported on July 8th, Branislav Bibic, Vice President for Sub-Saharan Africa at PMI, expressed concern over the slow adoption of new tobacco technology in African countries during the Technovation 2025 conference in Cape Town, South Africa.

 

Bibicchi stated that delaying the adoption of new technologies will put smokers at risk of developing cancer, respiratory issues, and cardiovascular disease. He said:

 

"It is easier to introduce new technologies in developed markets because people have more funds, higher purchasing power, and more information. We know that Africa has shown good performance in adopting new technologies, but there is often a delay."

 

The unique socio-economic landscape in Africa, including high poverty and unemployment rates, makes it more susceptible to the influence of tobacco industry marketing strategies and sets barriers for implementing effective tobacco control measures. Research has shown that balancing harm reduction potential with comprehensive tobacco control strategies is a key challenge.

 

Many African countries have weak or poorly enforced tobacco control laws, allowing the tobacco industry to operate almost unchecked. Research shows that challenges remain in regulating new nicotine products such as e-cigarettes and heated tobacco products.

 

Furthermore, the lack of unified regulatory measures between different African countries has resulted in inconsistent regulation of tobacco products. Insufficient funding from governments for tobacco control programs also hinders the implementation of effective policies and public health measures.

 

He stated that this undermines efforts for tobacco control and may lead to new technologies being seen as undesirable. However, he expressed confidence in the eventual entry of new technologies into the African market and confirmed that Philip Morris International (PMI) will continue to promote these products. He said:

 

"We believe that these new technologies will also expand in sub-Saharan Africa, with Philip Morris International (PMI) playing a key role. We will continue to invest in smoke-free products, not only in developed countries but also in Africa, where greater regulation and tax progress are needed."

 

Bibiqi pointed out that industries and consumers in Africa are eager to embrace new technologies and transition away from cigarettes. He stated:

 

"We are actively engaging with the community and policymakers to share the scientific basis of smoke-free products and their potential harm reduction. We are accelerating progress through the implementation of specific product regulations. While this is not a simple process, we are making every effort to do so."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
A smoke-free nicotine policy report argues that tobacco harm reduction should move beyond product bans and health warnings into tax policy, insurance pricing and risk-based regulation. While some projections remain open to debate, the report highlights a wider challenge: nicotine products, technologies and consumer behavior have changed sharply over the past decade, and regulatory systems may need new tools to better align tobacco control with harm-reduction goals.
Jun.08
EVO NXT 2026 Opens in Prague as Global NGP Industry Gathers for Two-Day Event
EVO NXT 2026 Opens in Prague as Global NGP Industry Gathers for Two-Day Event
2026 — EVO NXT 2026 officially opened today in Prague, bringing together manufacturers, brand owners, retailers, and decision-makers from across the global next-generation products (NGP) industry. As the event’s official media partner for the fourth consecutive year, 2Firsts is reporting on site, tracking key developments across the exhibition floor, forum agenda, and broader industry discussions.
Apr.17 by 2FIRSTS.ai
Product | ZYN Adds Tropical Flavor and Expands 1.5mg Nicotine Options in the Philippines
Product | ZYN Adds Tropical Flavor and Expands 1.5mg Nicotine Options in the Philippines
ZYN has expanded its nicotine pouch portfolio in the Philippines with the addition of Cool Breeze 1.5mg and Tropical in 3mg and 6mg strengths. Public information shows that 1.5mg is among the lower nicotine strengths offered by ZYN in the Philippine market and is positioned for adult nicotine consumers who are new to nicotine pouches.
PMI
Jun.08
PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai
French Anti-Tobacco Group Contre-Feu Calls for Plain Packaging Across All Vaping Products
French Anti-Tobacco Group Contre-Feu Calls for Plain Packaging Across All Vaping Products
French anti-tobacco group Contre-Feu said in a statement released on April 14 that e-cigarette manufacturers are encouraging nicotine dependence among young people through targeted marketing and called for concrete measures to protect minors. The group asked for plain packaging for all vaping products, strict regulation of flavor names, and a ban on online sales.
Apr.15 by 2FIRSTS.ai